We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-3 of 3

Court prohibits FDA from bringing charges against drugmaker Amarin for promoting fish oil drug for off-label uses
  • Loeb & Loeb LLP
  • USA
  • August 31 2015

A New York federal judge granted Amarin's bid for "preliminary relief," allowing the drugmaker to promote its Vascepa pill for off-label use without

Scott S. Liebman
  • Loeb & Loeb LLP